Publication | Open Access
The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
87
Citations
21
References
2020
Year
<sup>18</sup>F-FDG PET-CT can predict MPR to neoadjuvant sintilimab in resectable non-small cell lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1